ArticleOncotarget2015

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.

Chinthalapally V Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.